NASDAQ: MYL - Mylan

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Mylan

0.0790.0790.0630.0630.0470.0470.0320.0320.0160.0160.0000.000Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
133.29 57.21 132.97% 157.04 -15.12%
P/S 0.71 33.44 -97.88%
P/BV 0.73 4.65 -84.29%
P/FCF 5.78 39.66 -85.42%
Ev/Ebitda 7.46 -17.68 -142.2%
Ev/S 1.44 22.52 -93.59%
Ev/FCF 11.74 47.58 -75.32%
E/P 0.0325 0.0172 88.43%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
23.61 -14.58 -261.87% 12.98 +81.89%
ROE -12.42 9.48 -230.98%
ROA -4.64 0.1068 -4444.67%
ROIC -4.82 7.63 -163.14%
ROS 2.31 -26.35 -108.77%
ROCE 0 14.58 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
4/10
3.4 -3.62 -193.8% 3.4 0%
Nеt Debt/Ebitda 3.1 -4.05 -176.62%
Debt/Ratio 0.2955 0.1841 60.48%
Debt/Equity 0.7358 1.6 -53.9%
Debt/Net Income 34.66 0.9168 3680.37%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5448 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0.4286 0.2387 79.53%
Average dividend growth 15.63 1.55 909.41%
Average percentage for 5 years 0 0.4954 -100%
Average percentage for payments 18.25 43.69 -58.24%
Difference from average difference in sector -0.5448

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
3.88 31.71 -87.76%
Growth impulse Ebitda in 5 years -5.1 -23.28 -78.09%
Growth impulse Net Income in 5 years -212.6 -33.08 542.68%
Growth impulse FCF in 5 years -57.48 -8.35 588.38%
Growth impulse EPS in 5 years 144.44 -64.95 -322.39%
IP Score
3.96/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription